255 related articles for article (PubMed ID: 24743704)
1. Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts.
Li S; Li L; Zhu Y; Huang C; Qin Y; Liu H; Ren-Heidenreich L; Shi B; Ren H; Chu X; Kang J; Wang W; Xu J; Tang K; Yang H; Zheng Y; He J; Yu G; Liang N
Br J Cancer; 2014 May; 110(11):2812-20. PubMed ID: 24743704
[TBL] [Abstract][Full Text] [Related]
2. High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.
Guedes JG; Veiga I; Rocha P; Pinto P; Pinto C; Pinheiro M; Peixoto A; Fragoso M; Raimundo A; Ferreira P; Machado M; Sousa N; Lopes P; Araújo A; Macedo J; Alves F; Coutinho C; Henrique R; Santos LL; Teixeira MR
BMC Cancer; 2013 Apr; 13():169. PubMed ID: 23548132
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.
Borràs E; Jurado I; Hernan I; Gamundi MJ; Dias M; Martí I; Mañé B; Arcusa A; Agúndez JA; Blanca M; Carballo M
BMC Cancer; 2011 Sep; 11():406. PubMed ID: 21943394
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002.
Couraud S; Vaca-Paniagua F; Villar S; Oliver J; Schuster T; Blanché H; Girard N; Trédaniel J; Guilleminault L; Gervais R; Prim N; Vincent M; Margery J; Larivé S; Foucher P; Duvert B; Vallee M; Le Calvez-Kelm F; McKay J; Missy P; Morin F; Zalcman G; Olivier M; Souquet PJ;
Clin Cancer Res; 2014 Sep; 20(17):4613-24. PubMed ID: 25013125
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers.
Dogan S; Shen R; Ang DC; Johnson ML; D'Angelo SP; Paik PK; Brzostowski EB; Riely GJ; Kris MG; Zakowski MF; Ladanyi M
Clin Cancer Res; 2012 Nov; 18(22):6169-77. PubMed ID: 23014527
[TBL] [Abstract][Full Text] [Related]
6. Actionable Mutation Profiles of Non-Small Cell Lung Cancer patients from Vietnamese population.
Dang AH; Tran VU; Tran TT; Thi Pham HA; Le DT; Nguyen L; Nguyen NV; Thi Nguyen TH; Nguyen CV; Le HT; Thi Nguyen ML; Le VT; Nguyen PH; Vo BT; Thi Dao HT; Nguyen LT; Van Nguyen TC; Bui QN; Nguyen LH; Nguyen NH; Thi Nguyen QT; Le TX; Do TT; Dinh KT; Do HN; Phan MD; Nguyen HN; Tran LS; Giang H
Sci Rep; 2020 Feb; 10(1):2707. PubMed ID: 32066856
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer.
Roosan MR; Mambetsariev I; Pharaon R; Fricke J; Husain H; Reckamp KL; Koczywas M; Massarelli E; Bild AH; Salgia R
Chest; 2021 Sep; 160(3):1095-1107. PubMed ID: 33878340
[TBL] [Abstract][Full Text] [Related]
8. Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX® HS, a new highly sensitive assay for the MassARRAY® System.
Sutton BC; Birse RT; Maggert K; Ray T; Hobbs J; Ezenekwe A; Kazmierczak J; Mosko M; Kish J; Bullock A; Shi Z; Stack MS; Irwin D
PLoS One; 2017; 12(9):e0183715. PubMed ID: 28926605
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia.
Palomba G; Colombino M; Contu A; Massidda B; Baldino G; Pazzola A; Ionta M; Capelli F; Trova V; Sedda T; Sanna G; Tanda F; Budroni M; ; Palmieri G; Cossu A; Contu M; Cuccu A; Farris A; Macciò A; Mameli G; Olmeo N; Ortu S; Petretto E; Pusceddu V; Virdis L
J Transl Med; 2012 Aug; 10():178. PubMed ID: 22931052
[TBL] [Abstract][Full Text] [Related]
10. Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer.
Ishida M; Iwasaku M; Doi T; Ishikawa T; Tachibana Y; Sawada R; Ogura Y; Kawachi H; Katayama Y; Nishioka N; Morimoto K; Tokuda S; Yamada T; Takayama K
Cancer Sci; 2024 May; 115(5):1656-1664. PubMed ID: 38450844
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutations in EGFR, KRAS and TP53 genes in human lung cancer tumors detected by ion torrent DNA sequencing.
Cai X; Sheng J; Tang C; Nandakumar V; Ye H; Ji H; Tang H; Qin Y; Guan H; Lou F; Zhang D; Sun H; Dong H; Zhang G; Liu Z; Dong Z; Guo B; Yan H; Yan C; Wang L; Su Z; Li Y; Jones L; Huang XF; Chen SY; Wu T; Lin H
PLoS One; 2014; 9(4):e95228. PubMed ID: 24760004
[TBL] [Abstract][Full Text] [Related]
12. Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients.
Erdem HB; Alay MT; Özdemir Z; Çevik E; Ateş Ö; Karaçin C; Şahin İ; Doğan M; Bahsi T
Mutat Res; 2024; 828():111847. PubMed ID: 38071953
[TBL] [Abstract][Full Text] [Related]
13. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap).
Dearden S; Stevens J; Wu YL; Blowers D
Ann Oncol; 2013 Sep; 24(9):2371-6. PubMed ID: 23723294
[TBL] [Abstract][Full Text] [Related]
14. Targeted molecular profiling of solid tumours-Indian tertiary cancer centre experience.
Gurav M; Epari S; Gogte P; Pai T; Deshpande G; Karnik N; Shetty O; Desai S
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7413-7425. PubMed ID: 36935431
[TBL] [Abstract][Full Text] [Related]
15. Variant Analysis of miRNA Regulatory Genes in 35 Sporadic Lung Carcinoma Tumors.
Bağcı Ö; Özdemir EM; Şanlıtürk B
Dokl Biochem Biophys; 2023 Dec; 513(Suppl 1):S1-S7. PubMed ID: 38472669
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours.
Capodanno A; Boldrini L; Alì G; Pelliccioni S; Mussi A; Fontanini G
Oncol Rep; 2012 Nov; 28(5):1559-66. PubMed ID: 22949056
[TBL] [Abstract][Full Text] [Related]
17. HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.
Da Silva L; Simpson PT; Smart CE; Cocciardi S; Waddell N; Lane A; Morrison BJ; Vargas AC; Healey S; Beesley J; Pakkiri P; Parry S; Kurniawan N; Reid L; Keith P; Faria P; Pereira E; Skalova A; Bilous M; Balleine RL; Do H; Dobrovic A; Fox S; Franco M; Reynolds B; Khanna KK; Cummings M; Chenevix-Trench G; Lakhani SR
Breast Cancer Res; 2010; 12(4):R46. PubMed ID: 20604919
[TBL] [Abstract][Full Text] [Related]
18. Tongue carcinoma infrequently harbor common actionable genetic alterations.
Tan DS; Wang W; Leong HS; Sew PH; Lau DP; Chong FT; Krisna SS; Lim TK; Iyer NG
BMC Cancer; 2014 Sep; 14():679. PubMed ID: 25234657
[TBL] [Abstract][Full Text] [Related]
19. Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity.
Chougule A; Prabhash K; Noronha V; Joshi A; Thavamani A; Chandrani P; Upadhyay P; Utture S; Desai S; Jambhekar N; Dutt A
PLoS One; 2013; 8(10):e76164. PubMed ID: 24124538
[TBL] [Abstract][Full Text] [Related]
20. Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.
Zhang JW; Qin T; Hong SD; Zhang J; Fang WF; Zhao YY; Yang YP; Xue C; Huang Y; Zhao HY; Ma YX; Hu ZH; Huang PY; Zhang L
Chin J Cancer; 2015 Apr; 34(4):177-83. PubMed ID: 25963410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
